Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The impact of biology on the treatment of secondary AML.
Gojo I, Karp JE. Gojo I, et al. Among authors: karp je. Cancer Treat Res. 2001;108:231-55. doi: 10.1007/978-1-4615-1463-3_12. Cancer Treat Res. 2001. PMID: 11702601 Review. No abstract available.
Progress against cancer.
Broder S, Karp JE. Broder S, et al. Among authors: karp je. J Cancer Res Clin Oncol. 1995;121(11):633-47. doi: 10.1007/BF01218521. J Cancer Res Clin Oncol. 1995. PMID: 7593127 Review. No abstract available.
New directions in molecular medicine.
Karp JE, Broder S. Karp JE, et al. Cancer Res. 1994 Feb 1;54(3):653-65. Cancer Res. 1994. PMID: 8306327 Review. No abstract available.
Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial.
Karp JE, Lancet JE, Kaufmann SH, End DW, Wright JJ, Bol K, Horak I, Tidwell ML, Liesveld J, Kottke TJ, Ange D, Buddharaju L, Gojo I, Highsmith WE, Belly RT, Hohl RJ, Rybak ME, Thibault A, Rosenblatt J. Karp JE, et al. Blood. 2001 Jun 1;97(11):3361-9. doi: 10.1182/blood.v97.11.3361. Blood. 2001. PMID: 11369625 Free article. Clinical Trial.
Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia.
Kaufmann SH, Karp JE, Letendre L, Kottke TJ, Safgren S, Greer J, Gojo I, Atherton P, Svingen PA, Loegering DA, Litzow MR, Sloan JA, Reid JM, Ames MM, Adjei AA, Erlichman C. Kaufmann SH, et al. Among authors: karp je. Clin Cancer Res. 2005 Sep 15;11(18):6641-9. doi: 10.1158/1078-0432.CCR-05-0817. Clin Cancer Res. 2005. PMID: 16166443 Clinical Trial.
292 results